This Article Full Text Full Text (PDF) All Versions of this Article: 200411-1603OEv1 171/7/699    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mitchison, D. A. Search for Related Content PubMed PubMed Citation Articles by Mitchison, D. A.

The Diagnosis and Therapy of Tuberculosis During the Past 100 Years

Medical Microbiology, Department of Cellular and Molecular Medicine, St. George's Hospital Medical School, London, United Kingdom

Correspondence and requests for reprints should be addressed to Denis A. Mitchison, M.B., F.R.C.P., F.R.C. Path, Medical Microbiology, Department of Cellular & Molecular Medicine, St. George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK. E-mail: dmitchis{at}sghms.ac.uk

ABSTRACT

Methods for the radiographic diagnosis of tuberculosis have improved from simple fluoroscopy to computerized tomography. Although direct smear examination is still the most widely used bacteriological method of diagnosis, cultural methods with selective liquid media are sensitive and rapid. The use of antituberculosis drugs has changed tuberculosis from a disease with about a 50% mortality, treated by measures to collapse the affected lung lesions and by rest for the patient, to a condition successfully curable by chemotherapy. Key steps in the development of modern chemotherapy regimens were the demonstrations in clinical trials that (1) streptomycin was effective; (2) combination of drugs prevented the emergence of drug-resistant Mycobacterium tuberculosis; (3) chemotherapy under domiciliary conditions was effective and did not put family members at risk of infection; (4) patient compliance could be assisted by fully supervised intermittent regimens, or more effectively, by (5) shortening treatment by the introduction of rifampin and pyrazinamide, the two most potent sterilizing drugs, into the regimens. Regimens were divided into an initial intensive phase, while bacterial populations were high, and a longer continuation phase to complete sterilization. Pyrazinamide was shown to sterilize only in the intensive phase. The treatment of nonpulmonary tuberculosis followed the same plan, but when bacterial populations are low, fewer drugs are required in combination.

This article has been cited by other articles:

				A. Grant, P. Gothard, and G. Thwaites Managing drug resistant tuberculosis BMJ, August 28, 2008; 337(aug28_1): a1110 - a1110. [Full Text]

				M. H. Baumann, R. Nolan, M. Petrini, Y. C. G. Lee, R. W. Light, and E. Schneider Pleural Tuberculosis in the United States: Incidence and Drug Resistance Chest, April 1, 2007; 131(4): 1125 - 1132. [Abstract] [Full Text] [PDF]

				K. Ewer, K. A. Millington, J. J. Deeks, L. Alvarez, G. Bryant, and A. Lalvani Dynamic Antigen-specific T-Cell Responses after Point-Source Exposure to Mycobacterium tuberculosis Am. J. Respir. Crit. Care Med., October 1, 2006; 174(7): 831 - 839. [Abstract] [Full Text] [PDF]

				W. W. Yew and C. C. Leung Prognostic significance of early weight gain in underweight patients with tuberculosis. Am. J. Respir. Crit. Care Med., August 1, 2006; 174(3): 236 - 237. [Full Text] [PDF]

				B. J. Marais, R. P. Gie, H. S. Schaaf, N. Beyers, P. R. Donald, and J. R. Starke Childhood Pulmonary Tuberculosis: Old Wisdom and New Challenges Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1078 - 1090. [Abstract] [Full Text] [PDF]